Concepedia

W. Pan

WP

5

Publications

182

Citations

5

H-Index

1996

Active since

Affiliations

Seoul National University Hospital(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Universidad Europea

W. Pan is an author at Seoul National University Hospital specializing in immunology, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

1996–2023

5

Publications

5

LBA16 KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · Annals of Oncology · 2021 · 52 citations · Full text

LBA18 Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study

Peter Schmid, Javier Cortés, Rebecca Dent et al. · Annals of Oncology · 2023 · 41 citations · Full text

, , +10

Cocaine and alcohol interactions in naive and alcohol-pretreated rats.

Mohsen A. Hedaya, W. Pan · Drug Metabolism and Disposition · 1996 · 35 citations

Preclinical development of<scp>AMG</scp>139, a human antibody specifically targeting<scp>IL</scp>‐23

Kathleen Köck, W. Pan, Jason M. Gow et al. · British Journal of Pharmacology · 2014 · 31 citations · Full text

A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24‐h intragastric pH

Jörg Täubel, Virender K. Sharma, Yi‐Lin Chiu et al. · Alimentary Pharmacology & Therapeutics · 2001 · 23 citations · Full text

Rows per page

1–5 of 5